This article summarized the latest R&D progress of imiglucerase, the Mechanism of Action for imiglucerase, and the drug target R&D trends for imiglucerase.

Moderna, Inc. reported encouraging preliminary outcomes from the mRNA-1083 Phase 1/2 study, a combination vaccine currently under investigation for its effect against both influenza and COVID-19.

This article summarized the latest R&D progress of infliximab-abda, the Mechanism of Action for infliximab-abda, and the drug target R&D trends for infliximab-abda.

Health-Related Quality of Life (HRQoL) is a significant indicator for assessing the quality of life and health status of patients.

Circular RNA (circRNA) is a type of single-stranded RNA with a closed loop structure, initially found in HDV and plant viruses.

Vedanta Biosciences recently reported the initiation of treatment for the initial participant in the COLLECTiVE202 Phase 2 investigation of VE202.

This article summarized the latest R&D progress of eflornithine hydrochloride, the Mechanism of Action for eflornithine hydrochloride, and the drug target R&D trends for eflornithine hydrochloride.

Clinical Benefit Rate (CBR) is defined as the percentage of advanced cancer patients who achieve complete remission, partial remission, or at least six months of stable disease after treatment.

This article summarized the latest R&D progress of efalizumab, the Mechanism of Action for efalizumab, and the drug target R&D trends for efalizumab.

BridgeBio Pharma and National Resilience Inc., which focus on genetic diseases, cancer pharmaceuticals, and tech-driven biomanufacturing respectively, announced a partnership to develop and produce BBP-812 and BBP-631, gene therapies for Canavan disease and congenital adrenal hyperplasia.

Proteolysis Targeting Chimeras (PROTACs) technology is a new protein degradation strategy that has emerged in recent years.

Pathological Complete Response (pCR) is commonly used as a surrogate marker for breast cancer and is defined as the absence of residual invasive cancer in the resected breast tissue and evaluated regional lymph node.